Todd Kunkel, PharmD

Senior Director, Scientific Communications
Collegium Pharmaceutical Inc.
Stoughton, Massachusetts

Disclosure information not submitted.

Presentation(s):

• Healthcare Cost and Resource Use in Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT

• Safety and Tolerability of Schedule III Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT

• Treatment Characteristics of Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT